Author

Sabino Riestra 1

1 Gastroenterology,Hospital Central de Asturias,Oviedo,Spain

CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. 

Ana Echarri Piudo, Isabel Vera Mendoza, Jordi Guardiola Capon, Virginia Ollero, Beatriz Castro, Francisco Gallego, Mariam Aguas, Maria Chaparro Sanchez, D Ceballos, Claudia Arajol, Pilar Robledo Andrés, Sabino Riestra, Ignacio Marín-Jiménez, Pilar Nos Mateu, S García-López

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EFFECTIVENESS AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Maria Chaparro, Sara Sulleiro, Iria Baston-Rey, Ivan Garcia Tercero, Federico Argüelles-Arias, Eduardo Leo, Cristina Rodriguez, Beatriz Sicilia, Patricia Ramírez de la Piscina, Sabino Riestra, Mercedes Cabello, Pilar Corsino, Maria Jose Garcia, Mariana Fé García-Sepulcre, José María Huguet, Pilar Martínez-Montiel, Fernando

EFFICACY AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF DRUG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

María José Casanova, Maria Chaparro Sanchez, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, Jordi Guardiola Capon, Antonio López-San Román, Eva Iglesias, Pilar Nos, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech Morral, Xavier Calvet Calvo, José Lázaro Pérez-Call

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, Jose Manuel Benitez, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emilio Torr

IDIOPATHIC ACUTE PANCREATITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTRIC COHORT STUDY

Ana García García de Paredes, Carlos Rodríguez-Escaja, Marisa Iborra, Alicia Algaba, Jose Ignacio Cameo, Luisa de la Peña, Fernando Gomollón, Manuel Van Domselaar, Reyes Busta, Enrique Rodríguez de Santiago, Andres Castaño García, Adolfo del Val, Fernando Bermejo, Ana Gutiérrez, Jordi Guardiola, Francisco Mesonero, Sabino

LONG-TERM DURABILITY AND SAFETY OF USTEKINUMAB (UST) IN PATIENTS WITH ACTIVE CROHN'S DISEASE (CD) IN REAL LIFE: SUSTAIN STUDY

Maria Chaparro, Sara Sulleiro, Iria Baston-Rey, Ivan Garcia Tercero, Federico Argüelles-Arias, Eduardo Leo, Cristina Rodriguez, Beatriz Sicilia, Patricia Ramírez de la Piscina, Sabino Riestra, Mercedes Cabello, Santiago García-López, Maria Jose Garcia, Mariana Fé García-Sepulcre, José María Huguet, Pilar Martínez-Montiel, F

QUALITY OF LIFE IN ULCERATIVE COLITIS IS ALREADY IMPAIRED BY MILD DISEASE ACTIVITY CRONICA-UC STUDY

Julian Panés, Pilar Nos Mateu, Eugeni Domenech Morral, Ignacio Marín-Jiménez, Sabino Riestra, Javier Gisbert, Xavier Calvet Calvo, Oscar Rincon, Cristina Romero, Luis Cea-Calvo, Berta Juliá De Páramo

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

Item 1 - 9 / 9
1